EA200800601A1 - Связывающие fas антитела - Google Patents

Связывающие fas антитела

Info

Publication number
EA200800601A1
EA200800601A1 EA200800601A EA200800601A EA200800601A1 EA 200800601 A1 EA200800601 A1 EA 200800601A1 EA 200800601 A EA200800601 A EA 200800601A EA 200800601 A EA200800601 A EA 200800601A EA 200800601 A1 EA200800601 A1 EA 200800601A1
Authority
EA
Eurasian Patent Office
Prior art keywords
mab
fas antibodies
antibodies
hfas
kits
Prior art date
Application number
EA200800601A
Other languages
English (en)
Inventor
Сьюзан Медгхалчи
Дженнифер Л. Олдрич
Original Assignee
ФАСДЖЕН ДАЙАГНОСТИКС, ЭлЭлСи
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ФАСДЖЕН ДАЙАГНОСТИКС, ЭлЭлСи filed Critical ФАСДЖЕН ДАЙАГНОСТИКС, ЭлЭлСи
Publication of EA200800601A1 publication Critical patent/EA200800601A1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/91Transferases (2.)
    • G01N2333/91045Acyltransferases (2.3)

Abstract

Описанное изобретение относится к моноклональным антителам (MAb), которые распознают синтетазу жирных кислот человека (hFAS) и отличаются от ранее известных антител против hFAS. Предусмотрены композиции, устройства и наборы, содержащие MAb, а также способы применения MAb во множестве способов применения.
EA200800601A 2005-08-17 2006-08-17 Связывающие fas антитела EA200800601A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70924605P 2005-08-17 2005-08-17
PCT/US2006/032510 WO2007022475A1 (en) 2005-08-17 2006-08-17 Fas binding antibodies

Publications (1)

Publication Number Publication Date
EA200800601A1 true EA200800601A1 (ru) 2009-08-28

Family

ID=37407696

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200800601A EA200800601A1 (ru) 2005-08-17 2006-08-17 Связывающие fas антитела

Country Status (8)

Country Link
US (2) US8247188B2 (ru)
EP (1) EP1924607A1 (ru)
KR (1) KR20080106157A (ru)
CN (1) CN101432308A (ru)
CA (1) CA2619763A1 (ru)
EA (1) EA200800601A1 (ru)
MX (1) MX2008002269A (ru)
WO (1) WO2007022475A1 (ru)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101720434A (zh) * 2007-02-27 2010-06-02 菲思根诊断学有限公司 肝病中的脂肪酸合酶
WO2009064927A2 (en) * 2007-11-13 2009-05-22 Fasgen, Inc. Phosphorylated fatty acid synthase and cancer
WO2010118324A2 (en) 2009-04-09 2010-10-14 Nuclea Biotechnologies, LLC Antibodies against fatty acid synthase
WO2010135475A2 (en) * 2009-05-19 2010-11-25 Fasgen Diagnostics Llc Phosphorylated fatty acid synthase and cancer
WO2011031517A1 (en) 2009-08-27 2011-03-17 Nuclea Biotechnologies, LLC Method and assay for determining fas expression
KR101138460B1 (ko) 2009-10-12 2012-04-26 한국생명공학연구원 항-fasn 자가면역 항체를 포함하는 간암 진단 마커 및 이의 항원을 포함하는 간암 진단용 조성물
US8846042B2 (en) 2011-05-16 2014-09-30 Fabion Pharmaceuticals, Inc. Multi-specific FAB fusion proteins and methods of use
CN105866420B (zh) * 2015-01-22 2018-11-16 艾托金生物医药(苏州)有限公司 一种检测免疫原的方法和装置
IL282614B2 (en) 2015-02-06 2024-02-01 Cell Idx Inc Antigen-conjugated immune reagents
JP7034489B2 (ja) 2016-03-15 2022-03-14 アイタブメッド (エイチケイ) リミテッド 多重特異性Fab融合タンパクおよびその使用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5759791A (en) * 1989-01-17 1998-06-02 The Johns Hopkins University Cancer related antigen

Also Published As

Publication number Publication date
CN101432308A (zh) 2009-05-13
US8247188B2 (en) 2012-08-21
CA2619763A1 (en) 2007-02-22
KR20080106157A (ko) 2008-12-04
US20120301467A1 (en) 2012-11-29
US20070148718A1 (en) 2007-06-28
EP1924607A1 (en) 2008-05-28
MX2008002269A (es) 2008-10-09
WO2007022475A1 (en) 2007-02-22

Similar Documents

Publication Publication Date Title
EA200800601A1 (ru) Связывающие fas антитела
EA200800812A1 (ru) Композиции антитела против cd3
EA201400933A1 (ru) Агенты, связывающие склеростин
PH12016501691A1 (en) Antibodies to matrix metalloproteinase 9
DK1937721T3 (da) Anti-IL-23 antistoffer
EA200802168A1 (ru) Гуманизированное антитело к с-kit
ATE534667T1 (de) Anti-abeta antikörper
EA201000424A1 (ru) Антитела к il-23
MA33757B1 (fr) Protéines de liaison à l'antigène de l'il-23 humaine
MY174493A (en) Binding agents
EP3255063A3 (en) Antibodies to matrix metalloproteinase 9
EA200801571A1 (ru) Композиции, содержащие молекулы ctl4-ig, и способы их получения
EA200700175A1 (ru) Композиции и способы лечения воспалительных заболеваний
DK1784426T3 (da) Humaniserede anti-beta7-antagonister og anvendelser deraf
HK1071586A1 (en) Transplant acceptance inducing cells of monocytic origin and their preparation and use
WO2011004028A3 (en) Tlr3 binding agents
EA201170357A1 (ru) Инженерные антитела к il-13: композиции, способы и применение
AU2009260320A8 (en) Antibodies to IL-6 and their uses
SG178886A1 (en) Humanized anti-cdcp1 antibodies
EA201390467A1 (ru) Композиции антител и способы применения
UA94211C2 (ru) Выделенное полностью человеческое моноклональное cd3 антитело
NO20084320L (no) Antistoffer mot EGFL7 og fremgangsmater for anvendelse av disse
EA202092508A1 (ru) Составы на основе антител к pd-l1 человека
UA108088C2 (xx) Сконструйоване антитіло проти tslp